The invention provides a traditional Chinese medicine composition for treating bronchial asthma in the acute-outbreak period. The traditional Chinese medicine composition comprises the following raw materials: fructus corni, semen lepidii, white mulberry root-bark, radix scutellariae, cortex lycii radicis, corydalis tuber, wadalee-gum-tree, dried ginger, iris tectorum maxim, aristolochia, fewflower lysionotus herb, celandine, saffron, American ginseng, cinnamon, physochlaina macrophylla, rhodiola, acanthopanax, changium smyrnioide, sea-buckthorn, japanese inula herb, salvia miltiorrhiza, bamboo shavings, lumbricus, pinellia ternate, cassia twig and garden balsam. The traditional Chinese medicine composition has the advantages of being capable of inhibiting the inflammatory reaction, reducing the airway hyperresponsiveness state, improving the micro-circulation, improving the pulmonary ventilation function and adjusting the immune function in the acute-outbreak period of the bronchial asthma; and compared with western medicines, the traditional Chinese medicine composition has the advantages of being capable of better improving the life quality of asthma patients and reducing the usage amount of glucocorticoids, having little toxic and side effects without drug tolerance and being low in cost.